Skip to main content
Clinical Trials/IRCT20210718051930N1
IRCT20210718051930N1
Not yet recruiting
Phase 3

Evaluation of the efficacy and safety of botulinum toxin type A injection with cross-linked hyaluronic acid in comparison with non cross-linked hyaluronic acid in the treatment of patients with icepick acne scar: A double blind controlled randomized clinical trial

Iran University of Medical Sciences0 sites16 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Iran University of Medical Sciences
Enrollment
16
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All patients with icepick acne scar in the range of 18 to 40 years
  • Having informed consent to participate in the study
  • Possibility to attend visit and follow\-up sections

Exclusion Criteria

  • Active acne
  • Inflammation or herpes simplex virus infection at the site of the procedure
  • Taking anticoagulants or NSAIDs within 48 hours before and in patients with platelet dysfunction or thrombocytopenia
  • Serious internal disease
  • Accompanying disease at the treatment site

Outcomes

Primary Outcomes

Not specified

Similar Trials